BCYC — Bicycle Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $335.79m
- -$222.87m
- $72.59m
Annual cashflow statement for Bicycle Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -66.8 | -113 | -181 | -169 | -219 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 12.6 | 27.2 | 33.5 | 35.8 | 39.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 38.1 | 0.672 | 76.7 | -33.4 | -75.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -14.8 | -86.1 | -60.6 | -165 | -250 |
| Capital Expenditures | -2.03 | -19 | -2.93 | -1.24 | -2.35 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -2.03 | -19 | -2.93 | -1.24 | -2.35 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 321 | 6.69 | 250 | 520 | -0.131 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 303 | -99.5 | 188 | 353 | -251 |